News

World

Audio News

Fews App News List News List

AIM ImmunoTech Stock Today: AIM Surges 44% on Massive Volume After Patent Approval and Cancer Trial Progress

AIM
International Business Times Fews App News Provider
Fews App Post Time 7h ago

Shares of AIM ImmunoTech Inc. (NYSE American: AIM) rocketed higher Wednesday, closing at $1. 02, up 31 cents or 43.

Go to Source
Related News
Fews App Loading
Login
Facebook Login
Twitter Login
Google Plus Login
Thank you for subscribing our newsletter
Your email has already been added to our subscibers list
Invalid email